About Diana Cirstea, MD

I grew up and received my medical degree in the Republic of Moldova. My passion for multiple myeloma ignited when I joined Noopur Raje’s translational research lab. My work focused on novel anti-myeloma therapeutics including CDK inhibitors and agents targeting PI3K/Akt/mTOR pathway both alone and in combination with conventional therapies. Next, during my three-year Hematology/Oncology Fellowship at Boston Medical Center I had the privilege to care for patients originating from diverse socio-economic and ethnic backgrounds, presenting with advanced malignancies, rare and often severe hematological conditions. There I developed an interest in stem cell transplant that led to my first job as a BMT hospitalist at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital, focusing on the inpatient care of patients receiving stem cell transplant and other forms of cell therapy including CAR-T. In August 2022 I joined the Mass General Cancer Center Multiple Myeloma Program, where I will be caring for patients with plasma cell disorders and conducting research, with a particular interest in cellular immunotherapy in myeloma.

Clinical Interests:




Mass General Cancer Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-5130
Phone: 877-726-5130

Mass General Cancer Center in Danvers
102 Endicott St.
Danvers, MA 01923
Phone: 978-882-6060

Medical Education

  • MD, State University of Medicine and Pharmacy Nicolae Testemitanu
  • Residency, Medical School Nicolae Testemitanu State University of Medicine, Dermatovenereology Residency Progra
  • Residency, Mount Auburn Hospital
  • Fellowship, Boston Medical Center
  • Fellowship, Dana Farber Cancer Institute

American Board Certifications

  • Hematology, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Reviews: Comments and Ratings